From lab signal to treating provider

Lab data can provide an early view into clinically meaningful patient activity. But the provider associated with a test is not always the clinician responsible for the patient’s treatment.

For commercial teams, that distinction matters.

Treating-provider enrichment adds context to the lab signal by connecting patient activity with additional provider and care-team information—helping teams better understand who may be actively managing care and making treatment decisions.

A more complete view of the patient journey

By combining harmonized lab data with longitudinal provider intelligence, commercial teams can better:

• Understand the role of the provider associated with a lab result
• Identify treating-provider relationships that may not be visible in the original record
• Expand and refine HCP targeting
• Incorporate enriched insights into existing analytics and activation workflows

See an example

In a recent rare disease program using Quest Diagnostics lab data, provider enrichment helped a specialty biopharma company expand its actionable NPI universe by an average of 220%, while treating-physician fill rates increased by 86%+. Read more here.

Interested in learning more?

Every therapeutic area, data environment and commercial use case is different.

Schedule a short conversation with the Prognos Health team to discuss how treating-provider enrichment works, the data available for your population, and where it may add context to your existing commercial strategy.